Vasculitis & polymyalgia rheumatica
External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic
Authors' conclusion
Our results showed an excellent AUC and sensitivity with a moderate specificity for classification of GCA patients.
Study context
- Population
- Patients with suspected giant cell arteritis (GCA) referred to a Dutch GCA fast-track clinic (Hospital Group Twente Early GCA in Twente prospective cohort)53 GCA, 80 non-GCA
- Participants
- 133 patients
- Comparison
- ACR/EULAR classification criteria for GCA (cut-off score ≥6) vs clinical diagnosis of GCA verified after 6 months (reference standard)
- Outcome
- AUC, sensitivity and specificity of the criteria vs clinical diagnosis
- Follow-up
- 6 months
Methodological detailsexternal validation, prospective cohort, fast-track clinic
- External validation
- Prospective cohort
- Fast-track clinic
Performance
As reported in the abstract
Diagnostic performance of the classification criteria
- Most misclassified patients without GCA had classification scores of 6 and 7
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic. RMD Open. Published 28 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →